BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37025999)

  • 1. Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature.
    Guo K; Liu X; Gong X; Li A; Liu Y; Li X; Zhou D; Hong Z
    Front Immunol; 2023; 14():1146536. PubMed ID: 37025999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
    Spatola M; Petit Pedrol M; Maudes E; Simabukuro M; Muñiz-Castrillo S; Pinto AL; Wandinger KP; Spiegler J; Schramm P; Dutra LA; Iorio R; Kornblum C; Bien CG; Höftberger R; Leypoldt F; Titulaer MJ; Sillevis Smitt P; Honnorat J; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2020 Dec; 95(22):e3012-e3025. PubMed ID: 32928978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.
    Spatola M; Sabater L; Planagumà J; Martínez-Hernandez E; Armangué T; Prüss H; Iizuka T; Caparó Oblitas RL; Antoine JC; Li R; Heaney N; Tubridy N; Munteis Olivas E; Rosenfeld MR; Graus F; Dalmau J
    Neurology; 2018 May; 90(22):e1964-e1972. PubMed ID: 29703767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease.
    Schnell S; Knierim E; Bittigau P; Kreye J; Hauptmann K; Hundsdoerfer P; Morales-Gonzalez S; Schuelke M; Nikolaus M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis.
    Lin J; Wang J; Li J
    Neurol Sci; 2023 Sep; 44(9):3253-3259. PubMed ID: 37010671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.
    Heine J; Ly LT; Lieker I; Slowinski T; Finke C; Prüss H; Harms L
    J Neurol; 2016 Dec; 263(12):2395-2402. PubMed ID: 27604620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid.
    Guevara C; Farias G; Silva-Rosas C; Alarcon P; Abudinen G; Espinoza J; Caro A; Angus-Leppan H; de Grazia J
    Front Immunol; 2018; 9():2568. PubMed ID: 30455705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-metabotropic glutamate receptor 5 encephalitis: Five case reports and literature review.
    Chen S; Ren H; Lin F; Fan S; Cao Y; Zhao W; Guan H;
    Brain Behav; 2023 May; 13(5):e3003. PubMed ID: 37060179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-metabolic glutamate receptor 5 encephalitis with gangliocytoma: a case and review of the literature.
    Shi K; Zhao H; Li Y; Li X; Chen W
    BMC Neurol; 2024 Jan; 24(1):27. PubMed ID: 38218780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
    Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
    Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
    J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
    Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
    Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
    Scotton WJ; Karim A; Jacob S
    Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCLC and anti-GABABR encephalitis: A retrospective analysis of 60 cases in China.
    Jiang C; Zhu M; Wei D; Duan H; Zhang Y; Feng X
    Thorac Cancer; 2022 Mar; 13(6):804-810. PubMed ID: 35132785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and prognostic analysis of anti-gamma-aminobutyric acid-B (GABA-B) receptor encephalitis in Northeast China.
    Zhang X; Lang Y; Sun L; Zhang W; Lin W; Cui L
    BMC Neurol; 2020 Jan; 20(1):1. PubMed ID: 31900128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
    Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
    Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
    Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningoencephalitis associated with GAD65 autoimmunity.
    Kuang Z; Baizabal-Carvallo JF; Mofatteh M; Xie S; Pan M; Ye J; Zhou L; Yang S; Wang Z; Chen Y; Li Y
    Front Immunol; 2023; 14():1120894. PubMed ID: 36969186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and brain MRI volumetric changes in anti-mGluR5 encephalitis.
    Sun Y; Tao JX; Han X; Wang X; Zhu Y; Lian Y; Ren G; Wang Q
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1407-1416. PubMed ID: 37329164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.